With the emergence and long-term Impact of COVID-19, Global Viral Vaccines Market to reach USD 107.58 Billion by 2030
Bizwit Research & Consulting LLP’s Recent Analysis on Global Viral Vaccines Market is poised to raise up to USD 107.58 Billion by 2030. Viral vaccines are immunizations that are specifically designed to prevent viral infections. They stimulate the immune system to recognize and mount a protective response against specific viral pathogens, reducing the risk of infection or the severity of the disease if infection occurs. The increasing government initiatives to promote vaccination, the increasing development of new products against these diseases, as well as the rising geriatric population are the prominent factors that are spurring the market demand around the world.
Geographically, the global Viral Vaccines market has been segmented into North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa (MEA). North America dominated the market in 2022 owing to the growing awareness and vaccination programs, rising technological advancements in vaccine development, and expanded vaccination coverage. Whereas Asia Pacific is expected to grow at the highest CAGR over the forecasting years. The increasing prevalence of viral diseases, rising government initiatives to encourage vaccination, and development of healthcare facilities are significantly propelling the market demand across the region.
The global Viral Vaccines market is highly competitive owing to the presence of several key manufacturers such as Seqirus (CSL Limited), Merck & Co., Inc., AstraZeneca plc, Emergent BioSolutions Inc., Novartis, Inc., GlaxoSmithKline plc, Pfizer, Inc. and others.
For further analysis on this or to request a sample copy of this report, please click the link mentioned below:
Key findings of the study suggest:
- Global Viral Vaccines Market is anticipated to grow with a healthy growth rate of more than 2.7% over the forecast period 2023-2030.
- In the Form segment, Liquid emerged out as the leading market segment in 2022.
- In the Container Format, Vials emerged out as the leading market segment in 2022.
- In the Biosafety Level Type, Biosafety Level 3 emerged as the leading market segment in 2022.
- North America is anticipated to drive regional growth growing awareness and vaccination programs, rising technological advancements in vaccine development, and expanded vaccination coverage.
- Asia-Pacific is expected to grow at higher rate followed by North America during 2023-2030.
Bizwit Research & Consulting has considered following segments for the study:
Form:
- Liquid
- Lyophilized
Container Format:
- Vials
- Prefilled Syringes
Biosafety Level Type:
- Biosafety Level 1
- Biosafety Level 2
- Biosafety Level 3
- Biosafety Level 4
Regional Outlook
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Korea
- Australia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
To get a sample of this report or to purchase a copy of the study, you can directly contact us at: sales@bizwitresearch.com
About Us
Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. The company has a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. Bizwit incorporate big data, expert analysis, and huge industry database to deliver client focused business consulting reports. Our analysts perform unbiased measurement and assessment of market opportunities to comprehend detailed market forecast. Our team of key opinion leaders evaluates the market size, growth prospects, end-use, applications, value & supply chain and top vendors in the industry to help the clients to take conversant business decisions without any vague assumptions.
Contact US
Global Business Development
Phone : +1 209 498-3066
Email: Sales@bizwitresearch.com
Website: www.bizwitresearch.com
